MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/20420986241237071

Медицинская библиотека · Therapeutic advances in drug safety · 2024

Structured medication reviews in Parkinson's disease: pharmacists' views, experiences and needs - a qualitative study.

Oonk Nicol G M, Dorresteijn Lucille D A, Te Braake Eline, Movig Kris L L, van der Palen Job, Nijmeijer Henk-Willem, van Kesteren Mirjam E, Bode Christina

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Executing structured medication reviews (SMRs) in primary care to optimize drug treatment is considered standard care of community pharmacists in the Netherlands. Patients with Parkinson's disease (PD) often face complex drug regimens for their symptomatic treatment and might, therefore, benefit from an SMR. However, previously, no effect of an SMR on quality of life in PD was found. In trying to improve the case management of PD, it is interesting to understand if and to what extent SMRs in PD patients are of added value in the pharmacist's opinion and what are assumed facilitating and hindering factors.

OBJECTIVES

To analyse the process of executing SMRs in PD patients from a community pharmacist's point of view.

DESIGN

A cross-sectional, qualitative study was performed, consisting of face-to-face semi-structured in-depth interviews.

METHODS

The interviews were conducted with community pharmacists who executed at least one SMR in PD, till data saturation was reached. Interviews were transcribed verbatim, coded and analysed thematically using an iterative approach.

RESULTS

Thirteen pharmacists were interviewed. SMRs in PD were considered of added value, especially regarding patient contact and bonding, individualized care and its possible effect in the future, although PD treatment is found already well monitored in secondary care. Major constraints were time, logistics and collaboration with medical specialists.

CONCLUSION

Although community pharmacist-led SMRs are time-consuming and sometimes logistically challenging, they are of added value in primary care in general, and also in PD, of which treatment occurs mainly in secondary care. It emphasizes the pharmacist's role in PD treatment and might tackle future drug-related issues. Improvements concern multidisciplinary collaboration for optimized SMR execution and results.

Для цитирования: Oonk Nicol G M, Dorresteijn Lucille D A, Te Braake Eline, Movig Kris L L, van der Palen Job, Nijmeijer Henk-Willem, van Kesteren Mirjam E, Bode Christina. Structured medication reviews in Parkinson's disease: pharmacists' views, experiences and needs - a qualitative study.. Therapeutic advances in drug safety. 2024. DOI: 10.1177/20420986241237071.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.